SQZ Biotechnologies Stock Price

0.02 (0.76%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 5,165
Bid Price
Ask Price
News -
Day High 2.74


52 Week Range


Day Low 2.59
Company Name Stock Ticker Symbol Market Type
SQZ Biotechnologies Company SQZ NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 0.76% 2.65 17:00:00
Open Price Low Price High Price Close Price Prev Close
2.61 2.59 2.74 2.65 2.63
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
67 5,165 $ 2.66 $ 13,746 - 2.0019 - 13.57
Last Trade Time Type Quantity Stock Price Currency
17:00:00 197 $ 2.65 USD


Draw Mode:

SQZ Biotechnologies Company Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 78.04M 29.45M 23.39M $ 27.10M $ - -2.48 -0.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -1.18k 4.00%

more financials information »

SQZ Biotechnologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SQZ Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.742.792.542.5616,524-0.09-3.28%
1 Month2.862.972.532.7117,465-0.21-7.34%
3 Months3.013.38752.00192.7840,591-0.36-11.96%
6 Months3.704.01712.00193.2591,022-1.05-28.38%
1 Year13.0013.572.00194.20189,092-10.35-79.62%
3 Years14.0036.492.00199.78167,893-11.35-81.07%
5 Years14.0036.492.00199.78167,893-11.35-81.07%

SQZ Biotechnologies Description

SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
Your Recent History
SQZ Biotec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221127 08:48:13